# Antireflux Ablation of the Cardia Mucosa vs Placebo for the Treatment of Gastroesophageal Reflux Disease

> **NCT04711655** · NA · COMPLETED · sponsor: **Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal** · enrollment: 64 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **PROCEDURE:** ARMA (antireflux ablation of the cardiac mucosa)
- **PROCEDURE:** upper digestive endoscopy

## Key facts

- **NCT ID:** NCT04711655
- **Lead sponsor:** Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-02-07
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04711655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04711655, "Antireflux Ablation of the Cardia Mucosa vs Placebo for the Treatment of Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04711655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*